Edward A. Stadtmauer, MD, sheds light on the future of chimeric antigen receptor T-cell therapy, systemic therapeutic advances in the field of acute myeloid leukemia, and remaining challenges in the multiple myeloma paradigm.
Chelsea LoCascio
Advertisement
Articles by Chelsea LoCascio
Advertisement
Latest Updated Articles
Personalized Medicine Moving to Forefront of Hematologic MalignanciesPublished: November 3rd 2017 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
M. Peter Marinkovich, MD, on Integrating Gene Therapy into Clinical Practice for Dermatologists
2
Quarter Century Update: How can Partnerships Between Academia, Biotech, and Pharma be Better Structured?
3
Quarter Century Update: Platform Approaches and Industry Investment
4
